Affluent Medical : Affluent Medical strengthens its management team to support industrial and commercial deployment

PRESS RELEASE Affluent Medical increases its management team to support commercial and industrial deployment Aix-en-Provence (16 January 2023 - 5 :45 - Affluent Medical) (ISIN code FR0013333077 - ticker AFME), a French MedTech specializing on the international development and industrialization innovative medical devices. It announced, after the arrival of Christophe Giot VP Clinical Affairs in the second half 2022, the appointment of three members to the management committee. This will prepare for the industrialization and the marketing and the three new medical devices: Kalios Artus, Epygon, Artus, Epygon, Kalios and Artus, Epygon. Celine Buard – Marketing Director Celine Buard is a graduate of ESCP Paris and holds a DU (Nutrition and Metabolic Diseases) from the University of Medicine Rennes. Celine Buard worked for 15 years in various sales and marketing roles in major healthcare organizations like Johnson&Johnson and Medtronic. Celine managed the Johnson&Johnson urinary incontinence products for many years. Celine, who spent 5 years at Eyetechcare in marketing and sales director roles, joined Truffle Capital as a Truffle Capital investor in June 2022. She also completed her cardiovascular experience with Caranx Medical. Olivier Belamy, Industrialization Director Olivier Belamy is a more experienced manager in large pharmaceutical companies, with over 20 years' experience in managing industrial performance, asset valuation, and organization. Olivier previously served as the COO of Robocath Robotics and Ecential Robotics. These companies specialize in robotics for interventional cardiology. Claire Andre - Quality Assurance manager Claire Andre has over 15 years experience in quality management in the medical device and pharmaceutical industries. Claire Andre was previously a quality manager in medical device companies that developed and marketed class III medical devices. Between 2018 and 2022 she joined Fill-Med Laboratories, a major player for anti-aging cosmetics and medical products. Claire Andre's career has been characterized by a solid background in injectable and implantable products as well as the associated standards and regulations. Affluent Medical continues the clinical development of its three innovative medical devices. Affluent Medical has a team that is highly experienced and complementing to prepare for industrialization and commercialization. Affluent Medical is currently looking into the best financing options for the next stage of its development. Affluent Medical, which is especially attentive to the equity market, plans to increase its capital in the first half 2023 with all of its shareholders. About Affluent Medical Affluent Medical, a French MedTech player, was founded by Truffle Capital with the aim of becoming a global leader for the treatment of heart disease and vascular diseases. Urinary incontinence currently affects 1 in 4 adults. Affluent Med develops next-generation implants that are minimally invasive and innovative to restore vital physiological functions. KaliosTM will be the first European medical device to go on sale. Contact URL for more information